desipramine has been researched along with Abdominal Pain in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinland, SR | 1 |
| Morris, CB | 1 |
| Dalton, C | 1 |
| Hu, Y | 1 |
| Whitehead, WE | 1 |
| Toner, BB | 1 |
| Diamant, N | 1 |
| Leserman, J | 1 |
| Bangdiwala, SI | 1 |
| Drossman, DA | 1 |
1 trial available for desipramine and Abdominal Pain
| Article | Year |
|---|---|
Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Cognition; Cognitive Beha | 2010 |